M-CSF serous rate evolution during post-transplantation days in a heterotopic heart graft model mice

J Cardiovasc Surg (Torino). 1997 Dec;38(6):567-70.

Abstract

Background: On heterotopic heart graft in mice, aged 7 weeks (C3H and B57), we investigate the variations of Macrophage Colony stimulating factor serous rate. The macrophage colony stimulating factor (M-CSF) is a cytokine involved in the immune response during transplantation.

Methods: Five groups were determined, group 1 with a heterotopic transplant without immunosuppressive treatment (N=24); group 2 with a heterotopic transplant and Corticoid treatment after the graft (N=29); group 3 with a heterotopic transplant and cyclosporine treatment after the graft (N=34); group 4 with an isogenic transplant (N=31) and group 5 undergoing a laparotomy (N=31). The mice are sacrificed at D4, D7, D10 or D14 and the M-CSF dosage are done by ELISA method.

Results: The serous rate of M-CSF is stable in the group with an isogenic transplant or with only a laparotomy. But in the group with a heterotopic transplant the M-CSF values increase (x1.5). If we use an immunosuppressive treatment the raising of M-CSF is less important. When we have a rejection graft, the serous rate of M-CSF increases but not significantly (Mann-Whitney test).

Conclusions: We conclude M-CSF seems to be a reliable index of disorder during immune response, but is not a good marker of the rejection.

MeSH terms

  • Animals
  • Biomarkers / blood
  • Disease Models, Animal
  • Graft Rejection / blood
  • Heart Transplantation / immunology*
  • Macrophage Colony-Stimulating Factor / blood*
  • Male
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Postoperative Period
  • Species Specificity
  • Transplantation, Heterotopic*

Substances

  • Biomarkers
  • Macrophage Colony-Stimulating Factor